GGHC
ONCE

Gilder Gagnon Howe & Co’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-507,941
Closed -$19.9M – 293
2018
Q4 		$19.9M Sell
507,941
-5,199
-1% -$225K 0.28% 77
2018
Q3 		$28M Sell
513,140
-12,904
-2% -$882K 0.29% 86
2018
Q2 		$43.5M Sell
526,044
-6,215
-1% -$480K 0.47% 68
2018
Q1 		$35.4M Sell
532,259
-15,930
-3% -$920K 0.44% 67
2017
Q4 		$28.2M Buy
+548,189
New +$39.4M 0.38% 71
2017
Q2 		– Sell
-6,887
Closed -$367K – 312
2017
Q1 		$367K Sell
6,887
-21
-0.3% -$1.25K 0.01% 219
2016
Q4 		$345K Sell
6,908
-4,587
-40% -$246K 0.01% 204
2016
Q3 		$690K Sell
11,495
-3
-0% -$173 0.01% 199
2016
Q2 		$588K Buy
+11,498
New +$491K 0.01% 200
2015
Q4 		– Sell
-11,802
Closed -$492K – 276
2015
Q3 		$492K Sell
11,802
-180,414
-94% -$9.42M 0.01% 204
2015
Q2 		$11.6M Sell
192,216
-264,388
-58% -$17.5M 0.15% 103
2015
Q1 		$35.4M Buy
+456,604
New +$26.3M 0.49% 52

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Gilder Gagnon Howe & Co's ONCE Position: Q1 2019 in Review

Gilder Gagnon Howe & Co sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 507,941 shares — an estimated $19.9M sold.

Gilder Gagnon Howe & Co first reported a position in ONCE in Q1 2015 and held it in 12 quarters. The position peaked at $43.5M in Q2 2018. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

  • Gilder Gagnon Howe & Co reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 507,941 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $19.9M.
  • Gilder Gagnon Howe & Co first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 12 quarters.
  • Gilder Gagnon Howe & Co's Spark Therapeutics, Inc. Common Stock position peaked at $43.5M in Q2 2018.
  • 199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2019, filed 17 May 2019.